Adjuvant endocrine therapy for breast cancer: don't ditch the switch!

MeSH terms

• Age Factors
• Antineoplastic Agents, Hormonal / administration & dosage
• Antineoplastic Agents, Hormonal / adverse effects
• Antineoplastic Agents, Hormonal / therapeutic use*
• Aromatase Inhibitors / administration & dosage
• Aromatase Inhibitors / adverse effects
• Aromatase Inhibitors / therapeutic use*
• Biomarkers, Tumor / blood
• Breast Neoplasms / blood
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / mortality
• Chemotherapy, Adjuvant
• Clinical Trials as Topic
• Endometrial Neoplasms / chemically induced*
• Evidence-Based Medicine
• Female
• Humans
• Meta-Analysis as Topic
• Precision Medicine
• Risk Assessment
• Risk Factors
• Survival Analysis
• Tamoxifen / therapeutic use
• Thromboembolism / chemically induced*
• Treatment Outcome
• Uncertainty